145 related articles for article (PubMed ID: 38704799)
21. A Pharmacovigilance Signaling System Based on FDA Regulatory Action and Post-Marketing Adverse Event Reports.
Hoffman KB; Dimbil M; Tatonetti NP; Kyle RF
Drug Saf; 2016 Jun; 39(6):561-75. PubMed ID: 26946292
[TBL] [Abstract][Full Text] [Related]
22. The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement.
Fusaroli M; Salvo F; Begaud B; AlShammari TM; Bate A; Battini V; Brueckner A; Candore G; Carnovale C; Crisafulli S; Cutroneo PM; Dolladille C; Drici MD; Faillie JL; Goldman A; Hauben M; Herdeiro MT; Mahaux O; Manlik K; Montastruc F; Noguchi Y; Norén GN; Noseda R; Onakpoya IJ; Pariente A; Poluzzi E; Salem M; Sartori D; Trinh NTH; Tuccori M; van Hunsel F; van Puijenbroek E; Raschi E; Khouri C
Drug Saf; 2024 Jun; 47(6):575-584. PubMed ID: 38713346
[TBL] [Abstract][Full Text] [Related]
23. Towards Automating Adverse Event Review: A Prediction Model for Case Report Utility.
Muñoz MA; Dal Pan GJ; Wei YJ; Delcher C; Xiao H; Kortepeter CM; Winterstein AG
Drug Saf; 2020 Apr; 43(4):329-338. PubMed ID: 31912439
[TBL] [Abstract][Full Text] [Related]
24. Development of a multivariate prediction model to identify individual case safety reports which require clinical review.
Gosselt HR; Bazelmans EA; Lieber T; van Hunsel FPAM; Härmark L
Pharmacoepidemiol Drug Saf; 2022 Dec; 31(12):1300-1307. PubMed ID: 36251280
[TBL] [Abstract][Full Text] [Related]
25. Validation of statistical signal detection procedures in eudravigilance post-authorization data: a retrospective evaluation of the potential for earlier signalling.
Alvarez Y; Hidalgo A; Maignen F; Slattery J
Drug Saf; 2010 Jun; 33(6):475-87. PubMed ID: 20486730
[TBL] [Abstract][Full Text] [Related]
26. Contribution of Causality Assessment for an Automated Detection of Safety Signals: An Example Using the French Pharmacovigilance Database.
Berbain T; Pariente A; Miremont-Salamé G; Grandvuillemin A; Micallef J; Chouchana L; Benkebil M; Théophile H;
Drug Saf; 2020 Mar; 43(3):243-253. PubMed ID: 31974775
[TBL] [Abstract][Full Text] [Related]
27. Reducing the noise in signal detection of adverse drug reactions by standardizing the background: a pilot study on analyses of proportional reporting ratios-by-therapeutic area.
Grundmark B; Holmberg L; Garmo H; Zethelius B
Eur J Clin Pharmacol; 2014 May; 70(5):627-35. PubMed ID: 24599513
[TBL] [Abstract][Full Text] [Related]
28. Integrating Regulatory Drug Label Information to Facilitate Evaluation of Adverse Events in Pharmacovigilance.
Hui TZ
Curr Drug Saf; 2020; 15(2):124-130. PubMed ID: 32091345
[TBL] [Abstract][Full Text] [Related]
29. Intelligent Telehealth in Pharmacovigilance: A Future Perspective.
Edrees H; Song W; Syrowatka A; Simona A; Amato MG; Bates DW
Drug Saf; 2022 May; 45(5):449-458. PubMed ID: 35579810
[TBL] [Abstract][Full Text] [Related]
30. A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases.
Coloma PM; Avillach P; Salvo F; Schuemie MJ; Ferrajolo C; Pariente A; Fourrier-Réglat A; Molokhia M; Patadia V; van der Lei J; Sturkenboom M; Trifirò G
Drug Saf; 2013 Jan; 36(1):13-23. PubMed ID: 23315292
[TBL] [Abstract][Full Text] [Related]
31. A Feasibility Study of Drug-Drug Interaction Signal Detection in Regular Pharmacovigilance.
Hult S; Sartori D; Bergvall T; Hedfors Vidlin S; Grundmark B; Ellenius J; Norén GN
Drug Saf; 2020 Aug; 43(8):775-785. PubMed ID: 32681439
[TBL] [Abstract][Full Text] [Related]
32. Artificial Intelligence for Drug Toxicity and Safety.
Basile AO; Yahi A; Tatonetti NP
Trends Pharmacol Sci; 2019 Sep; 40(9):624-635. PubMed ID: 31383376
[TBL] [Abstract][Full Text] [Related]
33. Signal Detection of Imipenem Compared to Other Drugs from Korea Adverse Event Reporting System Database.
Park K; Soukavong M; Kim J; Kwon KE; Jin XM; Lee J; Yang BR; Park BJ
Yonsei Med J; 2017 May; 58(3):564-569. PubMed ID: 28332362
[TBL] [Abstract][Full Text] [Related]
34. Pilot evaluation of an automated method to decrease false-positive signals induced by co-prescriptions in spontaneous reporting databases.
Avillach P; Salvo F; Thiessard F; Miremont-Salamé G; Fourrier-Reglat A; Haramburu F; Bégaud B; Moore N; Pariente A;
Pharmacoepidemiol Drug Saf; 2014 Feb; 23(2):186-94. PubMed ID: 23670805
[TBL] [Abstract][Full Text] [Related]
35. Early detection of pharmacovigilance signals with automated methods based on false discovery rates: a comparative study.
Ahmed I; Thiessard F; Miremont-Salamé G; Haramburu F; Kreft-Jais C; Bégaud B; Tubert-Bitter P
Drug Saf; 2012 Jun; 35(6):495-506. PubMed ID: 22612853
[TBL] [Abstract][Full Text] [Related]
36. Comparison of text processing methods in social media-based signal detection.
Gavrielov-Yusim N; Kürzinger ML; Nishikawa C; Pan C; Pouget J; Epstein LB; Golant Y; Tcherny-Lessenot S; Lin S; Hamelin B; Juhaeri J
Pharmacoepidemiol Drug Saf; 2019 Oct; 28(10):1309-1317. PubMed ID: 31392844
[TBL] [Abstract][Full Text] [Related]
37. Supervised signal detection for adverse drug reactions in medication dispensing data.
Hoang T; Liu J; Roughead E; Pratt N; Li J
Comput Methods Programs Biomed; 2018 Jul; 161():25-38. PubMed ID: 29852965
[TBL] [Abstract][Full Text] [Related]
38. Application and optimisation of the Comparison on Extreme Laboratory Tests (CERT) algorithm for detection of adverse drug reactions: Transferability across national boundaries.
Tham MY; Ye Q; Ang PS; Fan LY; Yoon D; Park RW; Ling ZJ; Yip JW; Tai BC; Evans SJ; Sung C
Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):87-94. PubMed ID: 29108136
[TBL] [Abstract][Full Text] [Related]
39. Towards early detection of adverse drug reactions: combining pre-clinical drug structures and post-market safety reports.
Liu R; Zhang P
BMC Med Inform Decis Mak; 2019 Dec; 19(1):279. PubMed ID: 31849321
[TBL] [Abstract][Full Text] [Related]
40. An artificial intelligence algorithm for co-clustering to help in pharmacovigilance before and during the COVID-19 pandemic.
Destere A; Marchello G; Merino D; Othman NB; Gérard AO; Lavrut T; Viard D; Rocher F; Corneli M; Bouveyron C; Drici MD
Br J Clin Pharmacol; 2024 May; 90(5):1258-1267. PubMed ID: 38332645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
